Should the cost of care for patients with glioblastoma influence treatment decisions?

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

This article presents the case of a patient with recurrent glioblastoma who questions whether he can or should pay for treatment with bevacizumab. There are differing views on the physician's role in dealing with cost and cost-effectiveness issues for patients, but it is becoming increasingly unrealistic for physicians to disregard the cost of cancer care when making treatment recommendations. Physicians need to be able to address cost issues in order to allow individual patients to make the best informed decision about what treatment option is the most beneficial and the "best value" for them.

Original languageEnglish
Pages (from-to)416-420
Number of pages5
JournalContinuum (Minneapolis, Minn.)
Volume18
Issue number2
DOIs
StatePublished - Apr 2012
Externally publishedYes

Fingerprint

Glioblastoma
Patient Care
Costs and Cost Analysis
Physicians
Physician's Role
Cost-Benefit Analysis
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Clinical Neurology
  • Genetics(clinical)

Cite this

Should the cost of care for patients with glioblastoma influence treatment decisions? / Dropcho, Edward.

In: Continuum (Minneapolis, Minn.), Vol. 18, No. 2, 04.2012, p. 416-420.

Research output: Contribution to journalArticle

@article{6fcf679ccf2947dab87de5d45331b364,
title = "Should the cost of care for patients with glioblastoma influence treatment decisions?",
abstract = "This article presents the case of a patient with recurrent glioblastoma who questions whether he can or should pay for treatment with bevacizumab. There are differing views on the physician's role in dealing with cost and cost-effectiveness issues for patients, but it is becoming increasingly unrealistic for physicians to disregard the cost of cancer care when making treatment recommendations. Physicians need to be able to address cost issues in order to allow individual patients to make the best informed decision about what treatment option is the most beneficial and the {"}best value{"} for them.",
author = "Edward Dropcho",
year = "2012",
month = "4",
doi = "10.1212/01.CON.0000413667.65668.ae",
language = "English",
volume = "18",
pages = "416--420",
journal = "CONTINUUM Lifelong Learning in Neurology",
issn = "1080-2371",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Should the cost of care for patients with glioblastoma influence treatment decisions?

AU - Dropcho, Edward

PY - 2012/4

Y1 - 2012/4

N2 - This article presents the case of a patient with recurrent glioblastoma who questions whether he can or should pay for treatment with bevacizumab. There are differing views on the physician's role in dealing with cost and cost-effectiveness issues for patients, but it is becoming increasingly unrealistic for physicians to disregard the cost of cancer care when making treatment recommendations. Physicians need to be able to address cost issues in order to allow individual patients to make the best informed decision about what treatment option is the most beneficial and the "best value" for them.

AB - This article presents the case of a patient with recurrent glioblastoma who questions whether he can or should pay for treatment with bevacizumab. There are differing views on the physician's role in dealing with cost and cost-effectiveness issues for patients, but it is becoming increasingly unrealistic for physicians to disregard the cost of cancer care when making treatment recommendations. Physicians need to be able to address cost issues in order to allow individual patients to make the best informed decision about what treatment option is the most beneficial and the "best value" for them.

UR - http://www.scopus.com/inward/record.url?scp=84859646528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859646528&partnerID=8YFLogxK

U2 - 10.1212/01.CON.0000413667.65668.ae

DO - 10.1212/01.CON.0000413667.65668.ae

M3 - Article

C2 - 22810136

AN - SCOPUS:84859646528

VL - 18

SP - 416

EP - 420

JO - CONTINUUM Lifelong Learning in Neurology

JF - CONTINUUM Lifelong Learning in Neurology

SN - 1080-2371

IS - 2

ER -